FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:1056-1057 September 4, 2008 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Soon the U.S. Senate will vote on a bill¹ with unprecedented implications for the health of the American people. The bill would, for the first time, grant authority to the Food and Drug Administration (FDA) to regulate tobacco products.

In late July, the House passed its version of the bill by a veto-proof margin, but the vote in the Senate is expected to be much closer. President George W. Bush, whose administration has not usually shown a keen interest in the health of the American public, has indicated that he will veto the bill if it comes to his desk. . . . [Full Text of this Article]

Related Letters:

The FDA and Tobacco Regulation
Yancy C.
Extract | Full Text | PDF  
N Engl J Med 2008; 359:2294, Nov 20, 2008. Correspondence

This article has been cited by other articles:

• Walker, N., Bullen, C., McRobbie, H. (2009). Reduced-nicotine content cigarettes: Is there potential to aid smoking cessation?. Nicotine Tob Res 11: 1274-1279 [Abstract] [Full Text]  
• Frishman, W. H. (2009). Smoking cessation pharmacotherapy. Ther Adv Cardiovasc Dis 3: 287-308 [Abstract]  
• Yancy, C. (2008). The FDA and Tobacco Regulation. NEJM 359: 2294-2294 [Full Text]